Parallax Volatility Advisers’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-120,500
| Closed | -$578K | – | 2195 |
|
|
2023
Q4 | $578K | Buy |
120,500
+17,700
| +17% | +$108K | ﹤0.01% | 1565 |
|
|
2023
Q3 | $744K | Buy |
+102,800
| New | +$821K | ﹤0.01% | 1482 |
|
|
2023
Q1 | – | Sell |
-57,600
| Closed | -$592K | – | 3035 |
|
|
2022
Q4 | $592K | Sell |
57,600
-83,100
| -59% | -$1.47M | ﹤0.01% | 1833 |
|
|
2022
Q3 | $2.56M | Buy |
140,700
+128,000
| +1,008% | +$5.55M | ﹤0.01% | 1297 |
|
|
2022
Q2 | $653K | Sell |
12,700
-150,500
| -92% | -$7.8M | ﹤0.01% | 1800 |
|
|
2022
Q1 | $12M | Sell |
163,200
-29,900
| -15% | -$2.67M | 0.01% | 676 |
|
|
2021
Q4 | $27.6M | Buy |
193,100
+85,600
| +80% | +$14.7M | 0.03% | 350 |
|
|
2021
Q3 | $22.3M | Buy |
107,500
+83,700
| +352% | +$18.4M | 0.02% | 423 |
|
|
2021
Q2 | $5.05M | Buy |
23,800
+13,800
| +138% | +$2.53M | 0.01% | 658 |
|
|
2021
Q1 | $1.81M | Buy |
+10,000
| New | +$1.99M | ﹤0.01% | 716 |
|
|
2020
Q4 | – | Sell |
-48,400
| Closed | -$5.24M | – | 3082 |
|
|
2020
Q3 | $5.24M | Buy |
+48,400
| New | +$5.9M | ﹤0.01% | 1295 |
|
|
2020
Q1 | – | Sell |
-19,450
| Closed | -$77K | – | 2641 |
|
|
2019
Q4 | $77K | Hold |
19,450
| – | – | ﹤0.01% | 2176 |
|
|
2019
Q3 | $98K | Hold |
19,450
| – | – | ﹤0.01% | 1981 |
|
|
2019
Q2 | $114K | Sell |
19,450
-10,000
| -34% | -$78.7K | ﹤0.01% | 1836 |
|
|
2019
Q1 | $324K | Buy |
29,450
+25,700
| +685% | +$811K | ﹤0.01% | 1684 |
|
|
2018
Q4 | $138K | Hold |
3,750
| – | – | ﹤0.01% | 1850 |
|
|
2018
Q3 | $141K | Hold |
3,750
| – | – | ﹤0.01% | 1679 |
|
|
2018
Q2 | $101K | Buy |
+3,750
| New | +$127K | ﹤0.01% | 1478 |
|
|
2017
Q1 | – | Sell |
-2,500
| Closed | -$63K | – | 4285 |
|
|
2016
Q4 | $63K | Sell |
2,500
-115
| -4% | -$3.35K | ﹤0.01% | 2384 |
|
|
2016
Q3 | $109K | Buy |
2,615
+115
| +5% | +$14.8K | ﹤0.01% | 2089 |
|
|
2016
Q2 | $364K | Hold |
2,500
| – | – | ﹤0.01% | 1593 |
|
|
2016
Q1 | $258K | Sell |
2,500
-875
| -26% | -$93.9K | ﹤0.01% | 1675 |
|
|
2015
Q4 | $567K | Buy |
3,375
+2,875
| +575% | +$442K | ﹤0.01% | 1493 |
|
|
2015
Q3 | $71K | Buy |
+500
| New | +$112K | ﹤0.01% | 2085 |
|
|
2014
Q4 | – | Sell |
-1,250
| Closed | -$104K | – | 5568 |
|
|
2014
Q3 | $104K | Buy |
+1,250
| New | +$113K | ﹤0.01% | 2866 |
|
Other funds holding NVAX
SCM
Parallax Volatility Advisers's NVAX Position: Q3 2024 in Review
Parallax Volatility Advisers sold out of Novavax (NVAX) in Q3 2024, closing a stake of 19,588 shares — an estimated $248K sold.
Parallax Volatility Advisers first reported a position in NVAX in Q3 2014 and held it in 18 quarters. The position peaked at $29.3M in Q4 2021. 238 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.
- Parallax Volatility Advisers reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
- Parallax Volatility Advisers sold 19,588 Novavax shares in Q3 2024, an estimated $248K.
- Parallax Volatility Advisers first reported a position in Novavax in Q3 2014 and held it in 18 quarters.
- Parallax Volatility Advisers's Novavax position peaked at $29.3M in Q4 2021.
- 238 funds tracked by Wall St. Rank held Novavax as of Q3 2024.
Based on Parallax Volatility Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.